Literature DB >> 32067063

Paracrine signaling in islet function and survival.

Sean M Hartig1,2, Aaron R Cox3.   

Abstract

The pancreatic islet is a dense cellular network comprised of several cell types with endocrine function vital in the control of glucose homeostasis, metabolism, and feeding behavior. Within the islet, endocrine hormones also form an intricate paracrine network with supportive cells (endothelial, neuronal, immune) and secondary signaling molecules regulating cellular function and survival. Modulation of these signals has potential consequences for diabetes development, progression, and therapeutic intervention. Beta cell loss, reduced endogenous insulin secretion, and dysregulated glucagon secretion are hallmark features of both type 1 and 2 diabetes that not only impact systemic regulation of glucose, but also contribute to the function and survival of cells within the islet. Advancing research and technology have revealed new islet biology (cellular identity and transcriptomes) and identified previously unrecognized paracrine signals and mechanisms (somatostatin and ghrelin paracrine actions), while shifting prior views of intraislet communication. This review will summarize the paracrine signals regulating islet endocrine function and survival, the disruption and dysfunction that occur in diabetes, and potential therapeutic targets to preserve beta cell mass and function.

Entities:  

Keywords:  Diabetes; Islet biology; Islet function; Paracrine signaling; Survival

Mesh:

Substances:

Year:  2020        PMID: 32067063      PMCID: PMC7899133          DOI: 10.1007/s00109-020-01887-x

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  203 in total

1.  Zinc-induced changes in ionic currents of clonal rat pancreatic -cells: activation of ATP-sensitive K+ channels.

Authors:  A Bloc; T Cens; H Cruz; Y Dunant
Journal:  J Physiol       Date:  2000-12-15       Impact factor: 5.182

2.  Negative regulation of pancreatic and duodenal homeobox-1 by somatostatin receptor subtype 5.

Authors:  Guisheng Zhou; Shi-He Liu; Kelly M Shahi; Hua Wang; Xueyan Duan; Xia Lin; Xin-Hua Feng; Min Li; William E Fisher; Francesco J Demayo; David Dawson; F Charles Brunicardi
Journal:  Mol Endocrinol       Date:  2012-06-05

3.  Intra-islet insulin suppresses glucagon release via GABA-GABAA receptor system.

Authors:  Elaine Xu; Mohan Kumar; Yi Zhang; William Ju; Toshiyuki Obata; Nina Zhang; Shiying Liu; Anna Wendt; Shaoping Deng; Yousuke Ebina; Michael B Wheeler; Matthias Braun; Qinghua Wang
Journal:  Cell Metab       Date:  2006-01       Impact factor: 27.287

4.  An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes.

Authors:  Kevan C Herold; Brian N Bundy; S Alice Long; Jeffrey A Bluestone; Linda A DiMeglio; Matthew J Dufort; Stephen E Gitelman; Peter A Gottlieb; Jeffrey P Krischer; Peter S Linsley; Jennifer B Marks; Wayne Moore; Antoinette Moran; Henry Rodriguez; William E Russell; Desmond Schatz; Jay S Skyler; Eva Tsalikian; Diane K Wherrett; Anette-Gabriele Ziegler; Carla J Greenbaum
Journal:  N Engl J Med       Date:  2019-06-09       Impact factor: 91.245

5.  Antagonism of rat beta-cell voltage-dependent K+ currents by exendin 4 requires dual activation of the cAMP/protein kinase A and phosphatidylinositol 3-kinase signaling pathways.

Authors:  Patrick E MacDonald; Xiaolin Wang; Fuzhen Xia; Wasim El-kholy; Elisha D Targonsky; Robert G Tsushima; Michael B Wheeler
Journal:  J Biol Chem       Date:  2003-10-16       Impact factor: 5.157

6.  Insulin within islets is a physiologic glucagon release inhibitor.

Authors:  H Maruyama; A Hisatomi; L Orci; G M Grodsky; R H Unger
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

7.  Insulin and glucagon regulate pancreatic α-cell proliferation.

Authors:  Zhuo Liu; Wook Kim; Zhike Chen; Yu-Kyong Shin; Olga D Carlson; Jennifer L Fiori; Li Xin; Joshua K Napora; Ryan Short; Juliana O Odetunde; Qizong Lao; Josephine M Egan
Journal:  PLoS One       Date:  2011-01-25       Impact factor: 3.240

8.  Remodeling of hepatic metabolism and hyperaminoacidemia in mice deficient in proglucagon-derived peptides.

Authors:  Chika Watanabe; Yusuke Seino; Hiroki Miyahira; Michiyo Yamamoto; Ayako Fukami; Nobuaki Ozaki; Yoshiko Takagishi; Jun Sato; Tsutomu Fukuwatari; Katsumi Shibata; Yutaka Oiso; Yoshiharu Murata; Yoshitaka Hayashi
Journal:  Diabetes       Date:  2012-01       Impact factor: 9.461

9.  The regulator of G-protein signaling RGS16 promotes insulin secretion and β-cell proliferation in rodent and human islets.

Authors:  Kevin Vivot; Valentine S Moullé; Bader Zarrouki; Caroline Tremblay; Arturo D Mancini; Hasna Maachi; Julien Ghislain; Vincent Poitout
Journal:  Mol Metab       Date:  2016-08-26       Impact factor: 7.422

10.  δ-cells and β-cells are electrically coupled and regulate α-cell activity via somatostatin.

Authors:  L J B Briant; T M Reinbothe; I Spiliotis; C Miranda; B Rodriguez; P Rorsman
Journal:  J Physiol       Date:  2017-11-02       Impact factor: 5.182

View more
  7 in total

1.  Developmental programming: Prenatal testosterone excess disrupts pancreatic islet developmental trajectory in female sheep.

Authors:  Ian J Jackson; Muraly Puttabyatappa; Miranda Anderson; Meha Muralidharan; Almudena Veiga-Lopez; Brigid Gregg; Sean Limesand; Vasantha Padmanabhan
Journal:  Mol Cell Endocrinol       Date:  2020-07-26       Impact factor: 4.102

2.  Loss of growth hormone signaling in the mouse germline or in adulthood reduces islet mass and alters islet function with notable sex differences.

Authors:  Silvana Duran-Ortiz; Kathryn L Corbin; Ishrat Jahan; Nicholas B Whitticar; Sarah E Morris; Ania N Bartholomew; Kira G Slepchenko; Hannah L West; Ibiagbani Mercy Max Harry; Edward O List; John J Kopchick; Craig S Nunemaker
Journal:  Am J Physiol Endocrinol Metab       Date:  2021-05-03       Impact factor: 5.900

Review 3.  Making human pancreatic islet organoids: Progresses on the cell origins, biomaterials and three-dimensional technologies.

Authors:  Lai Jiang; Yiru Shen; Yajing Liu; Lei Zhang; Wei Jiang
Journal:  Theranostics       Date:  2022-01-03       Impact factor: 11.556

4.  Expression of Transient Receptor Potential Channel Genes and Their Isoforms in Alpha-Cells and Beta-Cells of Human Islets of Langerhans.

Authors:  Gabriel M Matos; Björn Andersson; Md Shahidul Islam
Journal:  J Diabetes Res       Date:  2022-08-03       Impact factor: 4.061

Review 5.  The endocrine pancreas during exercise in people with and without type 1 diabetes: Beyond the beta-cell.

Authors:  Olivia McCarthy; Signe Schmidt; Merete Bechmann Christensen; Stephen C Bain; Kirsten Nørgaard; Richard Bracken
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-06       Impact factor: 6.055

6.  Differential effects of RYGB surgery and best medical treatment for obesity-diabetes on intestinal and islet adaptations in obese-diabetic ZDSD rats.

Authors:  Ananyaa Sridhar; Dawood Khan; Mahmoud Abdelaal; Jessie A Elliott; Violetta Naughton; Peter R Flatt; Carel W Le Roux; Neil G Docherty; Charlotte R Moffett
Journal:  PLoS One       Date:  2022-09-22       Impact factor: 3.752

Review 7.  The Feasibility and Applicability of Stem Cell Therapy for the Cure of Type 1 Diabetes.

Authors:  Ryota Inoue; Kuniyuki Nishiyama; Jinghe Li; Daisuke Miyashita; Masato Ono; Yasuo Terauchi; Jun Shirakawa
Journal:  Cells       Date:  2021-06-24       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.